Exl Pharma’s 5th European Investigator Initiated Trials Conference is the foremost event that provides executives with a forum to network and learn from leading experts on how to improve strategies for IITs. As the technological and regulatory landscape continues to transform, the pharmaceutical and biotech industries must continue to adapt processes to remain compliant.
You will hear case studies on working with investigators, and ways to implement GCPs. This summit features best practices on improving funding, intellectual property, and contracting strategies. Your company will stay ahead of the curve by preparing for increases in regulation, including the possibility of audits, reviews and inspections.
Top Reasons to Attend
This conference is designed for representatives from pharmaceutical, biotechnology, and medical device companies with responsibilities in the following areas:
This conference is also of interest to: